scPharmaceuticals was founded on the belief that innovative technology could enable subcutaneous drug delivery for many important drug classes that now require IV administration. First pioneered over 175 years ago, subcutaneous delivery has proven its utility and importance in treating diabetes. Until now, technology shortcomings prevented its use with the many classes of drugs that require a larger volume of injection, such as antibiotics.
The benefits of subcutaneous drug delivery include:
- Flexibility in where, when, and by whom parenteral drugs are administered.
- No compromise in treatment – complete bioavailability (100%) with therapeutic levels within an hour.
- Freedom from risks, organizational burden, and high costs associated with vascular access and intravenous drug delivery.
We designed our sc2Wear™ Infusor to open the subcutaneous space and tap its benefits for routine, cost-effective administration of critical medicines such as antibiotics.
We are developing a portfolio of antibiotics that covers most common pathogens and infections and in doing so will eliminate routine use of PICC lines for treatment of infectious disease.
Our goal is to be known for great products; but also as a company that improves and makes care more affordable, is an admired place to work and delivers exceptional shareholder value.